Evidence map›Paper›PMID 33447352›Full record

ArticleOncotarget2020

Correction: Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer.

Shuai Zhang, Dehai Che, Fang Yang, Chunling Chi, Hongxue Meng, Jing Shen, Li Qi, Fang Liu, Liyan Lv, Yue Li and 4 more

Abstract readPublished Erratum
In one paragraph

Article in Oncotarget, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Shuai ZhangThe Sixth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Dehai CheThe Sixth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Fang YangThe Sixth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Chunling ChiDepartment of Neurology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Hongxue MengDepartment of Pathology, Harbin Medical University Cancer Hospital, Harbin, China.
Jing ShenThe Sixth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Li QiDepartment of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Fang LiuThe Sixth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Liyan LvDepartment of Oncology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yue LiThe Sixth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Qingwei MengThe Sixth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Junning LiuDepartment of Oncology, The First Affiliated Hospital of Qiqihar Medical College, Qiqihar, China.
Lihua ShangThe Sixth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Yan YuThe Sixth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.18632/oncotarget.21068.].

Identifiers

PMID33447352
PMCPMC7779255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.